Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 156.00
+1.00 (0.65%)
Sep 8, 2026, 1:30 PM CST
TPEX:6712 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,081 | 1,018 | 933.81 | 758.39 | 627.51 | 438.84 |
Revenue Growth | 9.10% | 8.96% | 23.13% | 20.86% | 42.99% | 521.61% |
Gross Profit Gross Profit Growth | 796.39 | 721.33 | 660.04 | 484.75 | 414.56 | 245.48 |
Operating Income Operating Income Growth | 477.39 | 439 | 421.19 | 337.73 | 283.8 | 116.2 |
Net Income Net Income Growth | 473.27 | 429.43 | 367.25 | 539.4 | 200.71 | 369.6 |
Earnings Per Share EPS Growth | 4.90 | 4.65 | 3.94 | 5.69 | 2.09 | 3.87 |
EPS Growth | 11.51% | 17.92% | -30.71% | 171.69% | -45.83% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Other Growth | 259.1 | 244.25 | 151.11 | 143.59 | 137.7 | 48.2 |
Cell Preparations Cell Preparations Growth | 822.04 | 773.25 | 783.9 | 615.71 | 491.26 | 353.63 |
Adjustment and Elimination Adjustment and Elimination Growth | - | - | -1.19 | -0.91 | -1.45 | -0.19 |
Total Total Growth | 1,081 | 1,018 | 933.81 | 758.39 | 627.51 | 401.64 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,057 | 435.66 | 938.18 | 1,335 | 1,270 | 1,344 |
Total Debt Total Debt Growth | 232.54 | 38.75 | 2.84 | 5.9 | 17.86 | 34.42 |
Net Cash (Debt) Net Cash Growth | 824.75 | 396.91 | 935.33 | 1,329 | 1,252 | 1,309 |
Net Cash Growth | 244.60% | -57.56% | -29.63% | 6.19% | -4.40% | 252.17% |
Net Cash Per Share Net Cash Per Share Growth | 8.55 | 4.30 | 10.03 | 14.02 | 13.07 | 13.69 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 631.54 | 536.35 | 440.34 | 421.74 | 319.2 | 135.69 |
Capital Expenditures CapEx Growth | -0.92 | -1.28 | -4.85 | -5.82 | -3.19 | -1.98 |
Free Cash Flow Free Cash Flow Growth | 630.63 | 535.07 | 435.49 | 415.92 | 316.02 | 133.7 |
Free Cash Flow Growth | 8.96% | 22.87% | 4.70% | 31.61% | 136.35% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.66% | 70.89% | 70.68% | 63.92% | 66.06% | 55.94% |
Operating Margin | 44.16% | 43.14% | 45.11% | 44.53% | 45.23% | 26.48% |
Pretax Margin | 53.69% | 51.53% | 49.34% | 82.15% | 42.09% | 90.42% |
Profit Margin | 43.77% | 42.20% | 39.33% | 71.12% | 31.99% | 84.22% |
FCF Margin | 58.33% | 52.59% | 46.63% | 54.84% | 50.36% | 30.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 3.333 | 3.333 | 4.329 | 4.723 | 1.431 | 3.253 |
Dividend Per Share Growth | -24.82% | -23.00% | -8.33% | 229.90% | -56.00% | - |
Dividend Yield | 2.12% | 2.19% | 3.01% | 3.34% | 1.00% | 2.68% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.86 | 33.45 | 38.55 | 26.58 | 74.86 | 35.21 |
Forward PE | 33.57 | 28.18 | 42.17 | 41.07 | 44.55 | - |
P/FCF Ratio | 24.92 | 26.85 | 32.51 | 34.47 | 47.55 | 97.33 |
PS Ratio | 14.53 | 14.12 | 15.16 | 18.91 | 23.94 | 29.65 |